目的 通过观察隔姜灸神厥穴并同时口服黄芪汤治疗脓毒症急性肾损伤患者的效果分析,初步探讨该方法能否改善患者的APACHEⅡ评分,入住重症监护病房的时间有没有缩短,14天内死亡率有否差异。方法 以2014年1月—2015年8月于我院确诊的脓毒症急性肾损伤患者为研究对象,观察常规治疗(对照组)及常规治疗基础上给予隔姜灸神厥穴同时口服黄芪汤治疗(治疗组)对脓毒症急性肾损伤患者危重情况的影响。结果 治疗组患者的危重指标(APACHEⅡ评分)明显改善,患者治疗5天后组间比较差异有统计学意义(P<0.05);两组患者入住重症监护病房的时间比较,患者治疗第四周χ²=4.5241,P=0.0334,差异有统计学意义(P<0.05);14天死亡率差异无统计学意义(P>0.05)。结论 隔姜灸神厥穴同时口服黄芪汤治疗能有效改善脓毒症急性肾损伤患者的APACHEⅡ评分,入住重症监护病房的时间减少。

目的 探讨分娩前后母体血浆D-二聚体的变化及其在预测和预防静脉血栓栓塞症的临床意义。方法 回顾性分析2015年5月在东莞市长安医院分娩的、产前与产后均进行了D-二聚体检测,产前与产后均未使用抗凝药物并产后随访6周的102例产妇的临床资料。结果 分娩后48~72小时,75.5%的产妇血浆D-二聚体水平下降,24.5%的产妇血浆D-二聚体水平升高。血浆D-二聚体水平升高的产妇60%存在发生VTE的高危因素,经积极预防,无静脉血栓栓塞症病例发生。结论 比较分娩前后母体血浆D-二聚体水平是有临床意义的。对分娩后母体血浆D-二聚体水平升高者,尤其是存在血栓高危因素者应高度重视,积极预防静脉血栓栓塞症。

目的 探讨低频脉冲超声联合微泡对微血管的渗出作用。方法 20只新西兰大白兔分为4组:空白组、单纯微泡组、单纯超声组、超声微泡组,进行实验观察。用频率为1 MHz,声压2000 MPa的脉冲超声辐照兔肠系膜及肠壁血管,在荧光显微镜下观察辐照前后肠系膜及肠壁上微血管的损伤,并静脉注入伊文思蓝溶液,观察超声辐照后对伊文思蓝溶液的渗出。结果 空白组、单纯微泡组、单纯超声组在超声辐照后肠系膜及肠壁上微血管内血流通畅,注入伊文思蓝溶液后,微血管内呈蓝色染色,血管周围未见渗出;超声微泡组在超声辐照后微血管周围可见渗出,部分形成血肿。结论 低频脉冲超声联合微泡对微小血管管壁产生损伤作用,血管周围可见渗出,部分形成血肿。

目的 探讨分析腹腔镜胆囊切除术后漏诊临床病例。方法 回顾2012年9月—2015年9月2000余例腹腔镜胆囊切除术后漏诊15例临床资料,腹腔镜胆囊切除术后根据患者出现临床症状进行并检查或病理回报合并疾病,确诊并选择治疗方式。结果 漏诊原因为胆总管结石3例、意外胆囊癌9例、结肠癌2例,胃巨大溃疡1例。结论 警惕腹腔镜胆囊切除术漏诊,术前应尽可能全面检查、注意鉴别诊断,减少漏诊,避免术后非计划再次手术的发生。

目的 研究低分子肝素联用乙酰半胱氨酸治疗间质性肺炎的疗效观察以及对其安全性进行评估。方法 选取间质性肺炎患者96例,随机分为对照46例及观察组50例,对照组予以常规治疗,观察组患者在对照组基础上联合加用低分子肝素和乙酰半胱氨酸,两组患者均接受为期3个月的疗程。比较治疗前后两组患者的临床症状、各项肺功能指标。结果 治疗后观察组患者呼吸困难自评分数和治疗前对比有改善(P＜ 0. 05),而治疗前后对照组无改变。 治疗后观察组的肺功能各项指标(VC% pred、FVC% pred、FEV1% pred、TLC% pred)比治疗前高;对照组经治疗后各项分功能指标的改善程度较治疗前差异不明显(P＞ 0.05); 且治疗后观察组的VC% pred、FVC% pred比对照组高。观察组在治疗后, HRCT 检测发现肺部出现磨玻璃影、网格影以及小叶间隔增厚的比例低于治疗前;而对照组以上指标治疗前后的改变比例差异无统计学意义 (P＞0.05) 。两组治疗后六分钟步行距离、血清Ⅲ型胶原水平较治疗前均有改善;但治疗后观察组的六分钟步行距离、血清Ⅲ型胶原水平高于对照组(P＜0.05)。治疗后两组患者没有发生明显不良反应。结论 联合应用低分子肝素、乙酰半胱氨酸来治疗间质性肺炎疗效显著,改善肺纤维化效果理想,且能帮助恢复患者的运动能力,研究过程中未发现明显不良反应,故提倡临床推广。

目的 评价综合营养干预措施与传统的单纯药物治疗对花都区老年原发性骨质疏松 (OP)患者生命质量的影响。方法 采用随机法将符合标准的OP患者随机分配到干预组(A组)和对照组(B组)接受相应的干预处理。干预组给予综合营养干预措施,而对照组只给予单纯的抗骨质疏松药物。结果 干预组人群干预前后生命质量的8个维度中的6个维度得分与干预前比较,差别有统计学意义(P<0.05)。 对照组人群生命质量的8个维度中只有2个维度与干预前比较,得分间差别有统计学意义(P<0.05)。结论 综合营养干预措施可以提高老年OP患者的生命质量。

目的 观察吉西他滨联合萘达铂治疗铂类敏感复发性卵巢癌的近期疗效与不良反应。方法 回顾性分析潍坊市人民医院2013年1月—2014年6月治疗的60例复发性卵巢癌病例,分为吉西他滨联合萘达铂(GN)方案化疗组30例和吉西他滨联合卡铂(GC)方案化疗组30例。GN方案组,吉西他滨1.0 g/m²,d1、8;萘达铂80 mg/m²,d1,21d为1周期;GC方案组,吉西他滨1.0 g/m²,d1、8;卡铂按AUC=5计算,d1,21 d为1周期。结果 GN方案组近期有效率56.0%,GC方案组近期有效率60.0%,两组比较差异无统计学意义(χ² =0.069,P=0.793)。两组最常见的毒性反应均是骨髓抑制,GC组骨髓抑制发生率较GN组骨髓抑制发生率稍高,但两组比较差异无统计学意义(P>0.05)。结论 两种方案治疗铂类敏感型复发性卵巢癌疗效无统计学差异,GN方案组不良反应较轻。

Objective To evaluate the clinical effect of GN chemotherapy protocol and GC chemotherapy protocol treatment of recurrent ovarian cancers. Methods We retrospectively analyzed the data of 60 patients with recurrent ovarian cancers in our hospital from January 2013 to June 2014. Divided into gemcitabine and nedaplatin (GN)chemotherapy group and Gemcitabine and carboplatin(GC)chemotherapy group, 30 patients in each group.Patients in GP protocol group were given Gemcitabine 1.0 g/m²,d1,8;and naphthalene(80 mg/m²,d1),21d was a period of treatment; Patients in GC protocol group were given gemcitabine 1.0 g/m²,d1,8;and carboplatin AUC=5 by calculation,21d was a period of treatment. Results For patients in GN protocol group,the short term response rate was 56.0%.For patients in GC protocol group,the short term response rate was 60.0%,the difference was not statistically significant(χ²=0.069,P=0.793). Two of the most common toxicities were myelosuppression, incidence of myelosuppression GC was slightly higher than GN, and the difference was not statistically significant. Conclusion The therapeutic effects of two chemotherapy protocols have no statistically significant difference in treatment of platinum sensitive recurrent ovarian cancer. Toxicity of GN group is light.

目的 为避免和减少颈部手术对喉返神经损伤,本文利用尸体解剖探讨喉返神经走向与分布以及与周围组织的相关性。方法 将20具用甲醛固定的成年尸体标本喉返神经(40侧)及其分支解剖;肉眼观察其与甲状腺、甲状腺下动脉和Berry's韧带相关性;测量喉返神经入喉点与甲状软骨下角的距离,以及甲状软骨下角至锁骨中点与胸骨柄上端的距离。结果 喉返神经与甲状腺下动脉交叉比例为96%,交叉点在甲状腺下极平面之上占88%,喉返神经位于甲状腺下动脉及其分支的前方与后方分别为22%与50%,经过Berry's韧带后方占95%,喉返神经入喉点至甲状软骨下角的距离(8.2±2.5)mm。结论 喉返神经与甲状腺下动脉和甲状腺韧带关系复杂,甲状软骨下角可作为喉返神经定位标志。

Objective In an attempt to reduce the risk of intraoperative recurrent laryngeal nerve (RLN) damage, human autopsy was conducted to determine the distribution of RLN and its relationship with surroundings. Methods With the naked eye observation, 20 formalin-fixed adult cadavers were examined. The relationships between RLN and inferior thyroid artery and inferior horn of thyroid cartilage were defined. Both the distance between entering point and inferior horn of thyroid cartilage and the distance between inferior horn of thyroid cartilage and middle point of clavicle bone or upper margin of stern were measured. Results The proportion of cases for recurrent laryngeal nerves intercrossed with inferior thyroid artery and for the crossing above the plane of inferior pole was respectively 88% and 96%. Therecurrent laryngeal never in front and rear of the inferi of thyroid artery and its branches were 22% and 50%,respectivdly.Most cases of RLN were behind Berry s suspensory ligament (95%). The distance between entering point of recurrent laryngeal nerve and inferior horn of thyroid cartilage was 8.2±2.5mm. Conclusion The results suggested that the correlation between RLN and its surrounding tissues is very complicated. The inferior horn of thyroid cartilage may be a useful marker for RLN.

目的 了解广州综合医院内分泌科门诊就诊者中抑郁焦虑障碍的患病率。方法 对广州市第一人民医院的内分泌科门诊就诊的患者进行横断面调查。采用医院焦虑抑郁量表(HADS)对105名入选的患者进行筛查,精神科医生对HADS≥8 分的患者进行国际神经精神科简式访谈问卷( MINI ) 的诊断性评估。结果 MINI诊断的抑郁障碍、焦虑障碍、抑郁和焦虑共病的患病率分别为3.80%、0.95%和2.86%。结论 抑郁和焦虑障碍是综合医院内分泌科门诊就诊者中的常见问题,但识别率和治疗率均不高。

Objective To investigate the prevalence rates of depressive and anxiety disorders of the endocrinology outpatients in a general hospital of Guangzhou. Methods A cross-sectional survey was conducted in the endocrinology outpatient department of Guangzhou First People's Hospital. A total of 105 outpatients were screened with hospital anxiety and depression scale(HADS). The patients with the HADS score of 8 and over were investigated and diagnosed by psychiatrists with the mini-international neuropsychiatric interview(MINI). Results The prevalence rates of MINI-diagnosed depressive disorder, anxiety disorder, and depressive-anxiety co-morbid disorders were 3.80%, 0.95% and 2.86%, respectively. Conclusion Depression and anxiety disorders are common problems in the endocrinology outpatient department of general hospitals,but few outpatients were well-diagnosed and treated.

目的 探讨ε-3多不饱和脂肪酸在胃肠道肿瘤患者化疗后的胃肠道毒性及生活质量的作用。方法 在研究前经过化疗筛选,按照WHO化疗副反应在2级或者以上的50名住院的胃癌或者直结肠癌患者,随机分为对照组(单纯化疗)(n=25)和研究组(化疗加ε-3多不饱和脂肪酸)(n=25),两组的化疗方案均为化疗筛选的方案。预防性每天静脉使用ε-3多不饱和脂肪酸 200 mg,连续5天,记录评估胃肠道并发症,如恶心、呕吐和腹泻,以及KPS评分、血清白蛋白、IL-2、IFN-γ和CRP。结果 与对照组比较,恶心、呕吐和腹泻评分、IL-2、IFN-γ和CRP低于于对照组,相反,生活质量评分研究组高于对照组,差异有统计学意义(P<0.05)。结论 预防性使用ε-3多不饱和脂肪酸能够减轻胃肠道肿瘤患者化疗后的胃肠道毒性症状、降低全身炎症因子反应并改善生活质量。

Objective To explore the effect omega-3polyunsaturated fatty acid omega-3 FA on clinical manifestations of gastrointestinal toxicity and quality of life (QOL) induced by chemotherapy for patients with gastric or colorectal cancer. Methods After screening chemotherapy, Fifty patients with gastric or colorectal cancer, according to developing WHO side-effect grading system of grade 2 or higher were randomly divided into either control group (n=25) or omega-3 FAs group (n=25) during next cycle of chemotherapy. In the control group, the patients received the same chemotherapy regimens as screening cycle and in the omega-3 FA group, received chemotherapy and omega-3 FAs. Prophylactic intravenous 200 mL /d was given for 5 days. The gastrointestinal complications such as nausea,vomiting or diarrhoea and Karnofsky performance status(KPS ),IL-2,IFN-γandCRP,ect, were evaluated respectively. Results Compared with the control group, the scores of nausea vomiting and diarrhea and IL-2,IFN-γor CRP levels decreased , significantly,on the contrary, the score of QOL increased. There was significantly statistical difference (P<0.05). Conclusion Prophylactic intravenous omega-3 FA can ameliorate clinical manifestations of gastrointestinal toxicity and systemic inflammatory response syndrome(SIRS) induced by chemotherapy and improve QOL for patients with gastric or colorectal cancer.